Rheumatoid arthritis (RA) is the most common autoimmune inflammatory arthritis in adults.
In June 2021, the ACR released an updated guideline for the treatment of rheumatoid arthritis.1 The guideline underscores the role of methotrexate as a cornerstone therapy and emphasizes minimizing glucocorticoids, when possible. It also includes new recommendations for specific high-risk groups. Learn more in our article. The ACR Convergence 2021 meeting reflected the continued advancement of science and practical research in the field of RA. Jeffrey Curtis, MD, MS, MPH, University of Alabama at Birmingham, offered an expert commentary on the research into JAK inhibitors, RA prevention tactics, COVID-19 and more.
FEATURED ARTICLE: Biologic or Conventional Therapy for Early RA?